Content validity and psychometric properties of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus^©) instrument in patients with COVID-19.

ABSTRACT:

Purpose

A well-defined and reliable patient-reported outcome instrument for COVID-19 is important for assessing symptom severity and supporting research studies. The InFLUenza Patient-Reported Outcome (FLU-PRO) instrument has been expanded to include loss of taste and smell in the FLU-PRO Plus, to comprehensively cover COVID-19 symptoms. Our studies were designed to evaluate and validate the FLU-PRO Plus among patients with COVID-19.

Methods

Two studies were conducted: (1) a qualitative, non-interventional, cross-sectional study of patients with COVID-19 involving hybrid concept elicitation and cognitive debriefing interviews; (2) a psychometric evaluation of the measurement properties of FLU-PRO Plus, using data from COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial-In

SUBMITTER: Keeley TJH 

PROVIDER: S-EPMC9879742 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature